skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib

Review

(2817) Views  (811) Full article downloads

Authors: Richard Quek, Suzanne George

Published Date February 2010 Volume 2010:4 Pages 19 - 31
DOI: http://dx.doi.org/10.2147/BTT.S4396

Richard Quek1, Suzanne George2

1Visiting Fellow, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 2Clinical Director, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Abstract: In the last decade a tremendous amount has been learned about the biology and treatment of gastrointestinal stromal tumor (GIST). Imatinib mesylate has revolutionized the treatment of metastatic GIST. In addition, the role of imatinib in localized GIST has gained much interest and may improve patient outcomes. Additionally, research efforts aimed at understanding the biology and the molecular heterogeneity of GIST both at initial presentation and at the time of resistance to imatinib, has helped guide rational approaches to treatment as well as future efforts aimed at treating imatinib-resistant GIST.

Keywords: gastrointestinal stromal tumors, GIST, review, imatinib, tyrosine kinase inhibitor, TKI








Readers of this article also read:

Therapeutic vaccines for malignant brain tumors
Current available therapies and future directions in the treatment of malignant gliomas
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Management of patients with advanced non-small cell lung cancer: role of gefitinib
Palliative treatment of malignant ascites: profile of catumaxomab
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed